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E-mail: Gilbert.Greub@chuv.chResults of positive blood culture are important since they help
to customize the antimicrobial therapy. MALDI-TOF MS has
dramatically modiﬁed the impact of positive blood-culture re-
sults, especially for Enterobacteriaceae [1]. Indeed, correct
identiﬁcation at species level was obtained in less than 2 hours
for 87% of cases [1,2]. However, early recognition of bacterialNew Microbes and New Infections © 2015 The Authors. Published by El
This is an open access artiresistance mechanisms such as β-lactamases, directly from
positive blood culture, remains challenging and important to
early tailor the antimicrobial therapy.
Recently, a rapid commercial test to detect β-lactamases
targeting third-generation cephalosporin (3GC) called the
ßLACTA test (Bio-Rad, Marnes-la-Coquette, France) was
evaluated on colonies [3,4]. This test is based on the cleavage of
a chromogenic cephalosporin, HMRZ-86. This cephalosporin
contain a carboxypropyloxyimino group comparable to cefta-
zidime which protect this compound from hydrolysis by class
A, C and D β-lactamase but is hydrolyzed in presence of
β-lactamases such as ESBLs, carbapenemases (KPC, MBL) and
acquired or derepressed AmpC [3–7].
The objective of our study was to apply the βLACTA test
directly to ammonium chloride-prepared bacterial pellets from
blood cultures positive for an Enterobacteriaceae. First, we
tested this assay on blood cultures spiked with various Enter-
obacteriaceae strains exhibiting different antibiotic resistance
mechanisms characterized molecularly [8,9]. Then, this method
was tested prospectively on clinical blood cultures positive for
an Enterobacteriaceae identiﬁed at species level by MALDI-TOF
MS [2].
Spiked blood cultures were prepared as follow: the β-lac-
tamase resistant and susceptible Enterobacteriaceae strains were
subcultured twice on Columbia agar. Then, blood culture vials
(BACTEC Lytic anaerobic/F) were inoculated with 5 ml of
human blood containing ~3 cfu/ml of bacteria to obtain a
detection time between 9 to 11 hours using the Bactec FX
system (Becton Dickinson, Sparks, USA).
Bacterial pellets from spiked blood culture or clinical pos-
itive blood culture were prepared as reported [2,10]. Brieﬂy,
5 ml from positive vial (BACTEC Lytic anaerobic/F or Plus
aerobic/F or Peds/F) were mixed with 40 ml sterile water and
centrifuged at 1000g for 10 min. The supernatant was
removed and the pellet was suspended in 1 ml of ammonium
chloride and centrifuged at 140g for 10 min. The supernatant
was discarded and the pellet suspended in 200μl of water. The
βLACTA test was performed as follow: 5μl of bacterial pellet
was mixed with 25μl of βLACTA test reagents R1 and R2 in
96 wells plates (Corning, NY, USA) gently agitated and
maintained at 20°C for 30 min before reading. Two reference
strains of Klebsiella pneumoniae were used as positive and
negative controls (ATCC BAA-1705, blaKPC+; ATCC BAA-
1706 blaKPC−). The test was considered as positive or
doubtful when the enzymatic reaction turned from yellow to
red or orange.
For clinical blood culture positive for Enterobacteriaceae,
bacterial pellets were used for direct antibiotic susceptibility
testing using AST-N242 cards (VITEK2 with software versionNew Microbe and New Infect 2015; 8: 1–3
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EUCAST standards (version 2012) were used for categorical
interpretation. Phenotypic tests, double disks synergy tests,
cefepime ± clavulanate E-tests (Etest ESBL PM/PML, bio-
Mérieux) and cefotetan ± cloxacillin E-test (AmpC Etest CN/
CNI, bioMérieux) were used to investigate 3GC resistance and
to conﬁrm the presence of ESBL, AmpC or hyperproduced
β-lactamase of K.oxytoca K1 [12–15].
The table presents the results on spiked blood cultures and
on positive clinical blood cultures. All ESBL strains gave a
positive reaction, except one that produced a doubtful color
(Escherichia coli TEM-53). One of 2 E. coli with plasmid-borne
AmpC gave a doubtful result, whereas 80% (12/15) of chro-
mosomal wild type AmpC or derepressed AmpC were negative
from species naturally producing AmpC β-lactamase. One
K. oxytoca strain with K1 hyperproduction gave a doubtful re-
action. Five tests with Oxa-48 (n=3), NDM (n=1) and KPC
(n=1) remained negative.
For clinical blood cultures, 137 bacterial pellets were tested
during 7 months. All 10 ESBL gave positive or doubtful results
(Table 1). Two K. oxytoca β-lactamases with 3GC resistance and
one Hafnia alvei were positive. All Enterobacter spp. and Serratia
marcescens were negative.TABLE 1. βLACTA test results for spiked blood cultures and clinic
species and resistance mechanisms
Microorganisms (no. of isolates) Phenotype or Genotype
Spiked blood cultures
Escherichia coli (14) ESBL
Plasmid-borne AmpC
OXA48
Klebsiella pneumoniae (12) ESBL (2 NDM, 2 KPC, 1 VIM)
Enterobacter spp. (11) AmpC hyperproduction (1 Oxa-48)
ESBL
Serratia marcescens (2) AmpC hyperproduction & KPC
Wild AmpC (inducible AmpC) & Oxa
Morganella morganii (2) AmpC hyperproduction & NDM
ESBL
Hafnia alvei (1) Wild AmpC (inducible AmpC)
Providencia stuartii (1) Wild AmpC (inducible AmpC) & VIM
Proteus vulgaris (1) 3GC susceptible
Klebsiella oxytoca (1) K1 hyperproduction
Clinical blood cultures
Escherichia coli (85) 3GC susceptible
AmpC
ESBL
Klebsiella pneumoniae (28) 3GC susceptible
ESBL
AmpC
Enterobacter spp. (8) Wild AmpC (inducible AmpC)
AmpC hyperproduction
Klebsiella oxytoca (5) 3GC susceptible
K1 hyperproduction
Serratia marcescens (4) Wild AmpC (inducible AmpC)
Proteus spp. (4) 3GC susceptible
Citrobacter koseri (1) 3GC susceptible
Salmonella Enteritidis (1) 3GC susceptible
Hafnia alvei (1) Wild AmpC (inducible AmpC)
aTEM-53
bmixed positive blood culture for E. coli ESBL and K. pneumoniae 3GC susceptible (this mixed
staining of blood culture suspension nor by MALDI-TOF performed on the bacterial pellet,
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strains obtained from blood culture and considering doubtful
and positive results as positive. Overall, the positive and nega-
tive predictive value were 100% (95%CI: 73.5–100%) and
96.8% (95%CI: 92–99.1%), respectively. Compared to the
manufacturer’s recommendations, we propose two adaptations
for use with blood culture bacterial pellets: i) reading the test at
30 min, ii) interpretation of any colorimetric change to orange
as doubtful, since this change may reﬂect a poor hydrolysis by
β-lactamase from bacterial pellets or sometimes also seen with
AmpC β-lactamase-producing Enterobacteriaceae with 3GC
resistance or K. oxytoca with hyperproduced β-lactamase K1.
Our results conﬁrm two recent studies that evaluated the
βLACTA test on colonies of Enterobacteriaceae [3,4]. Both
studies have observed an excellent sensitivity of 97.5%–100%
to detect ESBL. In these studies, positive βLACTA tests were
observed in 22% to 50% of derepressed AmpC and in 0% to
38% of plasmid-borne AmpC. Noteworthy, in a previous study
using the chromogenic cephalosporin HMRZ-86 on blood cul-
tures, only 42% of vials could be successfully tested, since lysed
blood apparently interfered with the test’s interpretation [16].al blood cultures. Results are presented according to bacterial
No. with βLACTA result of:
Positive Doubtful Negative
10 1a
1 1
1
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1
1
-48 1
1
1
1
1
1
1
76
3
5 1b
23
4
1
7
1
3
2
4
4
1
1
1
culture was detected only following subculture, being not detected neither by Gram
which identiﬁed only one species with a score >2)
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apparently overcame this interference. However, larger num-
ber of clinical isolates should be tested in the future to conﬁrm
the ﬁability of this test.
An alternative rapid test for the detection of ESBL from
positive blood cultures is based on the colorimetric detection
of hydrolysis of cefotaxime in presence of a pH indicator [17].
The results of this test applied to spiked blood cultures or
blood cultures bacterial pellets showed an excellent sensitivity
and speciﬁcity [17,18]. The authors mentioned that few ESBL
strains susceptible to cefotaxime were not detected. MALDI-
TOF assays allowing detection of extended β-lactamase or
carbapenemase directly from blood-culture bacterial pellets in
90 minutes to 4 hours were also described [19,20].
In conclusion, the application of the βLACTA test on
ammonium chloride-prepared bacterial pellets from blood
culture was found reliable to detect ESBL with a 100% positive
predictive value and may help clinicians managing patients with
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